Covid19
FDA: COVID-19 Moderna Vaccine Dose Needs to be Adjusted for Pediatric Population
The FDA is highlighting dosing information for Moderna's COVID-19 Vaccine (2023-2024 Formulation) in children aged 6 months to 11 years, after the …
The FDA is highlighting dosing information for Moderna's COVID-19 Vaccine (2023-2024 Formulation) in children aged 6 months to 11 years, after the …